![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 2, 896-906, January 11, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§¶
,
¶,
§**
From the Departments of
Stomatology,
§ Microbiology and Immunology, and
** Pharmaceutical Chemistry, University of California,
San Francisco, California 94143-0422
Received for publication, May 7, 2001, and in revised form, October 17, 2001
| |
ABSTRACT |
|---|
|
|
|---|
The chromosomal ends of Trypanosoma
brucei, like those of most eukaryotes, contain conserved
5'-TTAGGG-3' repeated sequences and are maintained by the action of
telomerase. Fractionated T. brucei cell extracts with
telomerase activity were used as a source of potential regulatory
factors or telomerase-associated components that might interact with
T. brucei telomeres. Electrophoretic mobility shift
assays and UV cross-linking were used to detect possible
single-stranded telomeric protein·DNA complexes and to estimate the approximate size of the protein constituents. Three single-stranded telomeric protein·DNA complexes were observed. Complex C3 was highly specific for the G-strand telomeric repeat sequence and shares biochemical characteristics with G-rich,
single-stranded telomeric binding proteins and with components of the
telomerase holoenzyme described in yeast, ciliates, and humans.
Susceptibility to RNase A or chemical nuclease (hydroxyl radical)
pre-treatment showed that complex C3 was tightly associated with an RNA
component. Matrix-assisted laser desorption/ionization-time of flight
mass spectrometry was used to estimate the molecular mass of the
peptides obtained by in-gel Lys-C digestion of low abundance
C3-associated proteins. The molecular masses of the peptides showed no
homologies with other proteins from trypanosomes or with any protein in
the data bases screened.
Telomeres are specialized protein·DNA complexes that form the
physical ends of eukaryotic chromosome (1). In Trypanosoma brucei, as in other eukaryotes, the essential telomeric DNA
consists of duplex tandemly repeated sequences of 5'-TTAGGG-3' (2, 3), which protrude toward the end of the chromosomes as 3' G-rich overhangs
that eventually form t-loop structures (4, 5). The lengths of
double-stranded telomeric DNA and of distal, G-rich single-stranded DNA
vary considerably between organisms and during the cell cycle, as well
as between different chromosomes in the same organism (6-9).
The higher order protein·DNA complex that caps the end of the
chromosomes is composed of a number of proteins that are associated with the double-stranded telomeric DNA, with the single-stranded G-rich
overhang, and with other accessory proteins (10-14). The abundant
yeast protein Rap1p, for example, binds to the double-stranded telomere
and to the most distal telomere sequences at the chromosome terminus,
where it acts as a negative regulator of telomerase elongation (13,
15). Rap1p also interacts with the telomeric silencing information
regulator proteins and controls the expression of genes positioned in
the proximity of telomeres (14, 16, 17). Proteins that share the same
functions with the yeast Rap1p and a mammalian Rap1p ortholog have also
been described (18, 19).
Telomerase reverse transcriptase, the enzyme that replicates eukaryotic
telomeres, is one of the better-characterized factors that bind
specifically to the 3'-G-rich overhang DNA. In addition to
telomerase, some non-conserved single-stranded telomeric
proteins that associate with the G-rich strand co-purify with
telomerase activity or the telomerase core subunits. The p80·p95
complex of Tetrahymena thermophila and the yeast Est1p
interact with the telomerase RNA component and are physically
associated with telomerase activity in vivo (10, 12, 20).
Other proteins, such as the yeast Cdc13p (21) and the In the African trypanosome T. brucei, the etiologic agent of
sleeping sickness, the telomeric environment is necessary (but not
sufficient) for the expression of variant surface glycoprotein genes or
antigenic variation (34, 35). Antigenic variation is essential for
parasite survival in its mammalian host and occurs when one of
thousands of different variant surface glycoprotein genes becomes
transcriptionally active. Transcriptional activation involves a complex
and only partially understood set of genomic rearrangements or gene
conversion events that place the variant surface glycoprotein gene in
question in a permissive telomeric environment (34-36). In related
parasites, such as Leishmania sp. and Trypanosoma
cruzi, telomeres and telomere-associated sequences are frequent
sites of recombination/amplification events (5, 33, 37, 38), which may
contribute to genomic variability/plasticity.
Eid and Sollner-Webb (39, 40) described two T. brucei
telomeric proteins, St1p and St2p, which are detected in S100 extracts of procyclic and bloodstream forms of the parasite. Each protein participates in the formation of two major telomeric complexes. The
39-kDa St1 protein preferentially binds to the double-stranded 29-bp
subtelomeric repeat region and to double-stranded telomeric repeats,
exhibiting greater affinity for their C-rich single-strands (39). St2
is a complex of proteins with affinity for duplex telomeric and
subtelomeric DNA sequences and has a greater affinity for the G-rich
strand of the telomere repeat. However, the greater affinity of this
complex is for the G-rich strand of the 29-bp subtelomere repeat. St1p
is necessary for St2 DNA binding and is apparently part of the complete
St2 DNA binding complex (40). Field and Field (41) also reported the
existence of a G-strand-binding protein in T. brucei nuclear
extracts, but the protein·DNA complex was not identified or
characterized. Recently, Cano et al. (42) described
telomerase activity in semipurified extracts of three evolutionarily
diverse kinetoplastid protozoa (T. brucei,
Leishmania major, and Leishmania
tarentolae). Some biochemical properties of the T. brucei telomerase were determined, and a minimal nine-nucleotide sequence for the template region of the T. brucei telomerase
RNA component was deduced from enzymatic activity profiles.
In this report, we used telomerase-containing fractions from T. brucei extracts as a source of potential components of the telomerase holoenzyme or of telomeric factors that might regulate T. brucei telomere maintenance. We identified three G-rich
single-stranded telomeric complexes (C1, C2, and C3). The proteins
associated with complex C3 (25- and 18-kDa protein bands) were purified
and subjected to MALDI-TOF
MS1 analysis and did not show
homology with any other trypanosome or proteins in the data bases
searched. We propose that C3-associated proteins are novel T. brucei single-stranded telomeric proteins.
Parasite Strains and Culture Conditions
Procyclic forms of T. brucei strain IsTat1.1 were
cultivated in Bienen's synthetic medium (43) supplemented with
5% heat-inactivated fetal bovine serum at 28 °C for 60 h.
Preparation of T. brucei Extracts
Telomerase-containing fractions were prepared from T. brucei extracts in the presence of protease inhibitors (see Ref.
42 for details). Briefly, S100 fractions were fractionated by
DEAE-agarose column chromatography (Biogel; Bio-Rad). The columns were
equilibrated with 1× TMG (50 mM Tris-HCl, pH 8.0, 1.5 mM MgCl2, 10% glycerol) and washed with six
volumes of 1× TMG containing 0.3 M sodium acetate, pH 8.0. Activity was eluted in one column volume each of 0.5 M
sodium acetate, pH 8.0, in 1× TMG. Fractions were then desalted with
Microcon-30 filters (Amicon) to a final salt concentration of 100 mM.
Telomerase Activity
1 µg of S100 or 1 µg of each DEAE-agarose fraction (300-500
mM sodium acetate) was assayed for telomerase
activity using a modification of the two-tube telomere repeat
amplification protocol (TRAP) assay as described in Ref. 42. Protein
extracts were assayed in a mixture containing 40 pmol of TS forward
primer (5'-AATCCGTCGAGCAGAGTT-3'), 1× modified TRAP buffer (50 mM Tris-HCl, pH 8.3, 1 mM dithiothreitol, 1 mM spermidine, 1 mM MgCl2), 2 mM dATP, 2 mM TTP, and 10 µM dGTP at 28 °C for 1 h. 10 µl of this reaction were added to a
50-µl PCR mix containing 50 µM of each dNTP, 20 pmol TS
primer, 20 pmol CX-ext reverse primer
(5'-GTGCCCTTACCCTTACCCTTACCCTAA-3'), and 0.1 µCi of
[ Preparation of Single-stranded, G-overhang, and
Double-stranded Oligomers
DNA or RNA oligonucleotides (see Table I for oligonucleotide
sequences) were purchased from Operon Technologies and gel-purified before and after 5' end-labeling with [ Electrophoretic Mobility Shift Assay (EMSA)
The S100 and telomerase-positive cell fractions (1 µg each)
were incubated individually with 28 fmol of purified 5'
[ Competition Assays
Non-radiolabeled oligonucleotide competitors were added to the
binding reaction at concentrations 10 (0.28 pmol), 50 (1.4 pmol), and
100 times (2.8 pmol) greater than the amount of 5' [ Quantitative analysis of the shifted complexes in the presence or
absence of molar excess of unlabeled competitors was done using Scion
Image software as above. The data were normalized to the amount of
complex present in the absence of competitor (defined as 100%) and
plotted. The Chi-Square test was used to test the null hypothesis of
equal distribution of the density areas of complexes C1, C2, and C3 in
the presence or absence of unlabeled competitors. We rejected the null
hypothesis by a significance level of 0.01 (p < 0.0001). When the expected counts were less than 5, the Fisher's Exact
Test was used.
Enzymatic and Chemical Treatment of Complexes
RNase A--
Extract containing 1 µg of protein was incubated
with 100 ng of RNase A for 10 min at 37 °C (before or after binding
to a labeled oligonucleotide and/or UV cross-linking). In some
reactions, 10 units of RNasin/µl was added to the extract just prior
to the addition of RNase A and before binding to the oligonucleotide.
DNase I--
Extract containing 1 µg of protein was incubated
for 10 min at 37 °C, before binding to the oligonucleotide, with 2 units of RQ1 RNase-free DNase I (Promega) in DNase I buffer
supplied by the manufacturer. EMSA and UV cross-linking controls were
done to confirm that DNase I did not bind to or compete with the probes used or otherwise interfere with the binding reactions (data not shown).
Hydroxyl Radical and Hydrogen Peroxide Treatment--
Each of
the reagents used for the hydroxyl radical experiments were tested by
EMSA. In these experiments, the telomerase extracts (DEAE 500 mM sodium acetate fraction) were pre-incubated with the
above reagents prior to the binding reactions and subsequently tested
by EMSA. Once shown that the protein·DNA binding was not perturbed by
any of the reagents, the extracts were tested in the hydroxyl radical
reactions to detect the presence of an RNA component in complex C3. The
samples were removed from ice for 1 min and allowed to reach room
temperature before hydroxyl radical treatment. Approximately 1 µg of
extract was incubated with 2 mM Fe/4 mM EDTA,
pH 8.0, 20 mM sodium ascorbate, and 0.03 or 0.003% H2O2 for 2 min at room temperature. The
reaction was stopped by adding 10% glycerol before proceeding with the
binding reaction described above. The percentage of binding activity of
the complexes after hydrogen peroxide and hydroxyl radical treatment
was quantified using the Scion Image software as mentioned before.
Proteinase K Digestion--
Extract containing 1 µg of protein
was treated with 10 µg of proteinase K (20 mg/ml; Invitrogen) for 10 min at 56 °C before binding.
UV Cross-linking
The 20-µl binding reaction mix was incubated on ice in
siliconized Eppendorf tubes covered with plastic film and placed 5-7 cm under 254-nm UV lamps for 15 min (45). These irradiation conditions,
which produced minimal damage to the telomere oligonucleotide structure
and to the complexes, were chosen after exposing free oligonucleotide
or the binding reaction mixture to irradiation for different times
followed by examination of the UV cross-linked products by SDS-PAGE
(data not shown). After irradiation, the samples were mixed with 2×
SDS loading buffer (44), boiled for 5 min, and loaded onto either 10%
gels or 4-20% pre-cast gradient gels (Bio-Rad). The gels were fixed
in 10% methanol, 5% glacial acetic acid for 30 min at room
temperature, dried, and exposed for 1-18 h to a Kodak X-Omat film at
MALDI-TOF MS Analysis Sequencing
Approximately 100 µg of the DEAE telomerase fraction (500 mM sodium acetate) was UV cross-linked with 2.8 pmol of
unlabeled tel 1 RNA oligonucleotide (as described above) and loaded
onto a preparative 12% polyacrylamide gel containing SDS. UV
cross-linking reactions were also done with 5' end-labeled tel 1 RNA
oligonucleotide (see above) and fractions containing telomerase
activity, which were run in the same gel containing the unlabeled
reaction. The unlabeled bands were excised based on the position of the
labeled bands corresponding to the complex C3-associated proteins of 25 and 18 kDa and were immediately frozen in a mixture of dry ice and
ethanol. The labeled and unlabeled protein complexes were eluted from
the gel matrix, separated by two-dimensional gel electrophoresis at
Kendrick Labs, Inc., (www.kendricklabs.com/), and silver
stained (unlabeled) or exposed to Kodak X-OMAT film (labeled). The
resulting protein spots were in-gel digested with Lys-C (Promega) and
subjected to MALDI-TOF MS at the Protein Chemistry Core Facility at
Howard Hughes Medical Institute (Columbia University, New York, NY), and to determine the molecular mass of the predicted peptide mass, fingerprints were compared with trypanosome
(www.parsun1.path.cam.ac.uk/) and protein data bases (Swiss-Prot)
using the Protein Prospector 3.2.1 MS-FIT 3.1.1 analysis program
(Baker, P. R. and Clauser, K. R.; www.prospector.ucsf.edu)
set at a mass tolerance (accuracy) of 50 ppm.
An RNase A-sensitive T. brucei Complex in Telomerase-containing
Fractions Specifically Interacts with Single-stranded G-rich Telomeric
DNA--
T. brucei S100 extracts and DEAE fractions
(300-500 mM sodium acetate) were assayed for the presence
of telomerase activity using a modification of the two-tube TRAP assay
(Fig. 1A, lanes 2-5). No enzyme activity was detected in S100 (Fig.
1A, lane 1) or in the 300 mM DEAE
fraction (Fig. 1A, lane 2). In contrast, the 400 and 500 mM DEAE fractions showed ladders of robust bands characteristic of products elongated by telomerase (Fig. 1A,
lanes 3-5). To confirm that the bands were produced by
telomerase activity, the DEAE 500 mM fraction was
pre-treated with 100 ng of RNase A, which abolished the enzyme activity
(Fig. 1A, lane 5).
To identify telomere-binding proteins with the same affinity for the
G-rich telomeric strand as telomerase, binding reactions were done
using the S100 and DEAE fractions and 5' end-labeled single-stranded
tel 4 oligonucleotide. Three T. brucei telomeric complexes
(C1, C2, and C3) were formed and detected at 4 °C using an
EMSA in non-denaturing 6% polyacrylamide gels. Two of the three complexes (C1 and C2) were formed using S100 or the DEAE 300-500 mM fractions and oligonucleotide tel 4 (Fig. 1B,
lanes 2-6). However, in the 500 mM fraction the
binding activities (Fig. 1B, bar graph at the
bottom of the gel) of complexes C1 and C2 were
reduced to ~56-50%, whereas the binding activity of complex
C3 was enriched in ~100% (compare in Fig. 1B, lanes
2 and 3 with lane 5). When the extracts were
tested for the presence of an RNA component that might indicate
association of the T. brucei telomerase holoenzyme with the
G-rich DNA telomeric oligonucleotide, only complex C3 was 100%
sensitive to RNase A pre-treatment (Fig. 1B, lane
6). In pilot experiments, varying amounts (0.2-5 µg) of S100
extracts were tested with 28 fmol of 5' end-labeled
T2AG3 probes, at room temperature or on ice in
the presence or absence of RNase A or oligonucleotide competitors (data
not shown). The results in Fig. 1C (gel lanes
1-10 and bar graph) show that complexes C1, C2, and C3
were formed when S100 was mixed with each one of the five 3' permuted
telomeric oligonucleotides (Fig. 1C, lanes 1,
3, 5, 7, and 9). Although
not yet understood, complexes C1, C2, and C3 were respectively and
preferentially formed when the assays were performed with tel 3 oligonucleotide, tel 1 oligonucleotide, and tel 5 oligonucleotide. The
pre-treatment of the extracts with RNase A (Fig. 1C,
lanes 2, 4, 6, 8, and
10) showed
To characterize the C3 binding activity, EMSAs were done using the
DEAE-agarose fraction containing telomerase activity (500 mM) and the 3' end permuted G-rich telomeric
oligonucleotides, as described above for the S100 extracts. Complexes
similar to those (C1-C3) shown in Fig. 1C were generated by
association of the telomerase fraction (500 mM) with the
five permuted oligonucleotides (Fig. 1D, lanes 2,
4, 6, 8, and 10).
Pre-treatment of the telomerase fraction with RNase A (Fig.
1D, lanes 3, 5, 7,
9, and 11) also showed that complex C3 formation
was highly reduced (2-4% of binding activity, compared with 65-68%
in extracts that were not treated with RNase A), and complex C2 was
enhanced in 5-65%, suggesting as in Fig. 1C that complexes
C2 and C3 are probably part of a larger complex. In addition, complexes
C1, C2, and C3 were not preferentially formed with any of the five 3'
end permuted telomeric oligonucleotides (compare graphs in
Fig. 1, C and D) when the telomerase fraction was
used as the protein source. Although the formation of complex C3
was reduced
The dependence of complex formation on the telomeric oligonucleotide
sequence was assessed by competition with increasing concentrations of
unlabeled G-strand telomeric sequence and non-telomeric oligonucleotides (the quantitative analysis of the experiments is
plotted in Fig. 2A,
bottom). S100 extracts were pre-incubated with a mix of
labeled oligonucleotide probe and unlabeled competitors (tel 4 and T7,
respectively). The concentrations of competitor used were 10 (0.28 pmol) and 50 (1.4 pmol) times greater than the amount of labeled probe
(28 fmol of labeled tel 4). As shown in Fig. 2A (lanes
4 and 5), the formation of the three labeled complexes
was completely prevented by high concentrations (1.4 pmol) of unlabeled
tel 4. The binding activity of complex C1 was reduced in 98% by,
respectively, 0.28 and 1.4 pmol of oligonucleotide T7 (Fig.
2A, lanes 6 and 7), suggesting that C1
is probably more specific for the T7 sequence. High concentrations of
T7 oligonucleotide (1.4 pmol) reduced in almost 90% the formation of
labeled complex C2, indicating that similar binding affinities are
observed with both tel 4 and T7 oligonucleotides (Fig. 2A,
compare lanes 2 and 7), implying the lack of
sequence specificity. In contrast, the percentage of binding activity
of complex C3 remained unaltered even in the presence of high
concentrations (1.4 pmol) of T7 oligonucleotide (Fig. 2A,
lanes 6 and 7) or the other four non-telomeric
sequence oligonucleotides tested (Fig. 2A and data not
shown). As an indirect control of C3 formation, the S100 extract was
pre-treated with RNase A and mixed in a binding reaction with labeled
tel 4 oligonucleotide (Fig. 2A, lane 3).
A 50 to 100 molar excess of unlabeled tel 1 or tel 5 oligonucleotides
was used in cross-competition assays with the 500 mM sodium
acetate fraction (Fig. 2B and data not shown). All three labeled complexes (C1, C2, and C3) were efficiently inhibited by both
oligonucleotides (Fig. 2B, lane 2 and data not
shown). Two nonspecific unlabeled oligonucleotides (CL9RC and CL9F2;
see Table I) based on sequences
from a T. cruzi subtelomeric region (38) were used in these
assays to ensure that the DNA binding was specific for T. brucei telomeric DNA. Both nonspecific oligonucleotides (CL9RC and
CL9F2) efficiently inhibited complex C1, reduced the binding activity
of complex C2 in 60-89% (Fig. 2B, lanes 3-6), and enhanced in 8.5-30% the binding activity of complex C3 (Fig. 2B, lanes 3-6). Binding assays were also done
with a C-stranded telomeric oligonucleotide, a duplex DNA formed
in vitro by tel 3 and tel C, and an oligonucleotide (Tet)
based on the T. thermophila telomeric sequence (Fig.
2C, lanes 3-7). The only complex formed with all
of the above single-stranded substrates migrated with the mobility of
C1 (Fig. 2C, lanes 1-6). Complexes C2 and C3
were formed only with tel 1 oligonucleotide (Fig. 2C,
lane 1) and were confirmed by the sensitivity of C3 to RNase
A (Fig. 2C, lane 2). The RNase A-sensitive
complex formed with tel C (Fig. 2C, lanes 3 and
4) had a very different mobility from C3 and most likely also had a different composition from that of the C3 complex formed with tel 1 (data not shown). One of the complexes formed with the
T. thermophila sequence also appeared to be RNase
A-sensitive although it migrated differently from complex C3 (Fig.
2C, compare lanes 5 and 6 with
lane 2). There was no complex formation with fully
double-stranded T. brucei telomeric DNA (Fig. 2C,
lane 7).
Complex C3 Binds Specifically to a Partially Duplex 3' G-overhang
Consisting of 17 Nucleotides of the G-rich T. brucei Telomeric
Strand--
The interaction of some telomere end-binding proteins is
specific for a free 3' terminus or for a G-rich 3' single-strand telomere extension from duplex DNA (3' G-overhangs; see Refs. 9-11).
We constructed a DNA fragment containing a 3' G-overhang that was
incubated with the 500 mM sodium acetate telomerase
fraction (see "Experimental Procedures" for DNA constructs). Fig.
3A shows that three complexes
were formed in the presence of this G-overhang construct (lanes
4-6). Relative to the single-stranded oligonucleotide binding
profile, the corresponding C1 complex was under-represented in the
G-overhang DNA profile (Fig. 3A, lanes 4 and
5). In contrast, a corresponding complex C3 was formed when
the G-overhang DNA construct was used as a probe (Fig. 3A,
compare lanes 2 and 4). When the 500 mM sodium acetate fraction was pre-treated with RNase A and
subsequently incubated with the G-overhang DNA, the band corresponding
to C3 in the single-strand DNA complex was not formed with the partial
duplex DNA (see complex C3* in Fig. 3A, lane 5).
This suggested that similar protein·DNA complexes were formed when
the telomerase fraction was incubated with the partially duplex
G-overhang DNA and the single-stranded tel 1 oligonucleotide. Despite
their apparent similarity to the single-stranded complexes, the
complexes formed with the partial duplex DNA (G-overhang), and the
telomerase fraction showed a different mobility in 6% native gels
probably because of the different DNA conformation acquired by
G-overhang DNA when compared with single-stranded DNA.
Complex C3 Is Highly Sensitive to Chemical Nuclease
Treatment--
According to Harrington et al. (46) the
complex formed by T. thermophila telomerase and a G-strand
telomeric DNA oligonucleotide is completely eliminated by pre-treating
the extracts with RNase. Thus, to further confirm the presence of an
RNA component in complex C3, the telomerase fraction (DEAE 500 mM sodium acetate fraction) was subjected to hydroxyl
radical treatment. Hydroxyl radicals can be generated in
vitro by the action of hydrogen peroxide on [Fe(II)
(EDTA)]2 The Size and Complexity of C3-associated Proteins Was Estimated by
UV Cross-linking Assays--
UV cross-linking experiments were done to
assess the size and complexity of the protein species associated with
complex C3. After UV irradiation, proteins cross-linked to tel 1 in the
S100 extract (Fig. 4, lanes 1 and 2) and the telomerase (500 mM) fraction (Fig. 4, lanes 3-8) were separated on 4-20% gradient
gels. Four prominent protein bands of ~18-50 kDa were obtained for
S100 (all molecular masses mentioned include the 18-nucleotide tel 1 oligonucleotide). Differences in the profile of the protein bands
between the S100 extract and the 500 mM fraction most
likely reflected variations in the purity of the fractions (compare in
Fig. 4, lanes 1 and 2 with lanes 5,
6, and 8). In the RNase A pre-treated and UV
cross-linked complexes formed with S100 extracts and tel 1 (Fig. 4,
lane 2) there was a complexed band of ~18 kDa which,
contrary to its counterpart in the telomerase fraction (Fig. 4,
lane 6), formed even after pre-treating the S100 extract
with RNase A and probably involved a protein found only in the S100
extract.
To further characterize the proteins in the 500 mM sodium
acetate fraction that may participate in complex C3 formation (Fig. 4,
lanes 3-8), extracts were pre-incubated with a 50-molar
excess of unlabeled CL9RC followed by a binding reaction with 5'
end-labeled tel 1 before UV irradiation (Fig. 4, lane 4).
Only the proteins bands corresponding to ~25 and 18 kDa were not
inhibited and cross-linked to tel 1 oligonucleotide. The 25- and 18-kDa
bands disappeared when the telomerase fraction was pre-treated with
RNase A (Fig. 4, lane 6), indicating that these bands are
probably part of C3. No protein bands were detected when tel 1 oligonucleotide was used as an unlabeled competitor (data not shown).
The telomerase fraction was pre-treated with 1 unit of DNase I to
eliminate the possibility of contamination by nicked telomeric DNA
(Fig. 4, lane 7). In other EMSA (data not shown), we
observed that only C3 remained when this protein fraction was treated
with DNase I, before or after oligonucleotide binding or after UV
irradiation. This result shows that DNase I does not interfere with the
formation of C3 (data not shown), which was also independent of the
absence or presence of bovine serum albumin in the reaction (Fig.
4, lane 8).
Formation of Complex C3 with the RNA Oligonucleotide Cognate of the
G-strand Telomere Sequence--
G-strand telomere-binding proteins
that bind more avidly to the RNA cognate of the DNA oligonucleotide
have been described in Chlamydomonas (48),
Saccharomyces cerevisiae (10, 11, 21), and T. thermophila (12). In Fig. 5,
A and B, the relative binding affinity of the
components of complex C3 associated with tel 1 RNA (Fig. 5A,
lanes 1-4) and tel 1 DNA (Fig. 5A, lanes
5-8), using the telomerase-positive (500 mM sodium
acetate) DEAE fraction, was judged by the amount of labeled complex and
by cross-competition assays among these oligonucleotides (see Fig.
5A, lanes 3 and 4, lanes 7 and 8, and line graph). In competition assays in
which tel 1 RNA was the probe and tel 1 DNA (1.4 or 2.8 pmol) was used as unlabeled competitor, C1 was completely abolished (no binding activity was detected), complex C2 was reduced in 40-50%, and C3
formation was diminished in 68-80%; a new complex with a faster migration than complexes C1, C2, and C3 was also observed (Fig. 5A, lanes 3 and 4). In these assays,
2.8 pmol of unlabeled tel 1 RNA was able to abolish 100% of complex C3
formation with labeled tel 1 DNA (compare lanes 7 and
8 with lanes 3 and 4 in Fig.
5A), although it was not possible to affirm that C3 proteins
bound more avidly to tel 1 RNA.
The association of the T. brucei single-stranded nucleic
acid binding components to tel 1 RNA was 50-90% reduced by RNase A
treatment, before or after binding to the RNA oligonucleotide (see Fig.
5B, top panel, lanes 3 and
5 and bottom panel, corresponding lanes
11 and 13). Complex C3 was 48% protected by the
addition of RNasin before pre-treating the extract with RNase A (see
Fig. 5B, top panel, lane 4 and
bottom panel, lane 12). Independently of the
probe used (tel 1 DNA or tel 1 RNA), pre-treating 1 µg of extract
with 10 µg of proteinase K completely abolished the formation of all
complexes (see Fig. 5B, top panel, lanes
6 and 7 and bottom panel, corresponding
lanes 13 and 14), indicating that all three
T. brucei single-stranded telomeric complexes were formed
mainly by the association of proteins and nucleic acid.
Although there is no information regarding the potential overlaps
between tel 1 RNA and tel 1 DNA binding sites, UV cross-linking data
suggested that the same proteins were most likely bound to both
oligonucleotides in all complexes (C1, C2, and C3). This conclusion was
based on a comparison of the size of the bands in Fig. 4 (lanes
4-8) with their counterparts in Fig. 5B (lanes 10 and 12).
Peptide Mass Fingerprint Analysis of C3-associated Proteins:
Preliminary Results--
Labeled and unlabeled 25- and 18-kDa protein
bands of UV cross-linked C3 complex, formed with the 500 mM
telomerase fraction and tel 1 RNA, were excised from a preparative 12%
gel and separated by two-dimensional gel electrophoresis. The gels were
silver-stained, and spots corresponding to the above protein bands were
compared with their labeled counterparts after exposure to x-ray film
(see Fig. 6A, on the
left, gel 1 and gel 2 and on the
right corresponding autoradiographs). Because of
the low abundance of proteins in the spots, in both cases, only some
spots were subject to in-gel digestion with endoproteinase Lys-C and
subsequent characterization by MALDI-TOF MS. Fig. 6B shows
diagrams of the corresponding peptide maps of spots 2, 4, 5, and 8 from
the 25-kDa band and spot 2 from the 18-kDa band. The peptide peaks are
indicated in Daltons, and the underlined peaks were utilized in
searches of trypanosome and protein data bases using the Protein
Prospector MS-FIT analysis program (Baker, P. R. and Clauser,
K. R.; www.prospector.ucsf.edu). No homologues were found for
these peptides in the data bases searched.
In many organisms, telomeric G-rich single-stranded DNA provides
sites for telomere-binding proteins that protect the chromosome end
terminus or recruit telomerase action (23, 28, 49). Telomere
maintenance in most eukaryotes requires several
telomere/telomerase-associated proteins, in addition to the reverse
transcriptase protein (telomerase reverse transcriptase) and the
telomerase RNA (TER) (23). Proteins with overlapping features and
functions have been found in yeast, ciliates, and humans (12, 50-55),
indicating that telomere structure is organized and maintained by
generally conserved evolutionary mechanisms. The yeast EST
(ever short telomere) gene products Est1p, Est2, and Est3 (53) are associated with yeast telomerase RNA and
telomerase (20) and are involved in the regulation of telomere length.
In contrast to Rap1p and Trf1p, double-stranded telomere-binding
proteins that negatively regulate telomerase action (13, 16, 18), the
G-strand telomere-binding proteins Cdc13p and Est1p (10, 11, 21), are
considered positive regulators of telomerase action. Cdc13p protects
the end of the chromosomes by functioning as a cap and plays a role in
telomere replication by interacting with telomerase through binding to
Est1p (11, 50). Est1p is associated with TER and requires a free,
single-stranded 3' terminus, as well as the presence of Cdc13p, to
promote the recruitment of telomerase to telomeres (10, 20, 50).
The three protein·DNA complexes described here were formed in
vitro using trypanosome G-rich single-strand telomeric repeat sequences permuted at the 3' end and fractions of a T. brucei extract that contained telomerase activity (42). Complex C1 was the most nonspecific, because it (i) was eluted throughout the
DEAE-agarose column fractionation profile, (ii) appeared the same as
the complex formed by binding the C-strand telomere sequence and the
T. thermophila G-strand telomeric DNA, and (iii) was
competed by all non-telomeric sequences tested. Protein(s) of complex
C2 also eluted in all DEAE-agarose fractions (300-500 mM)
but was(ere) less concentrated in the telomerase-positive 500 mM fraction. Complex C2 was formed with all tel
oligonucleotides and with the cognate tel 1 RNA version of the G-rich
telomere strand, although it was almost totally competed by some
non-telomeric oligonucleotides. The possibility that all three
complexes (C1, C2, and C3) are the same complex or parts of the same
complex that are intimately associated cannot be excluded, because
competition with CL9RC and CL9F2 reduced the formation of complexes C1
and C2 and enhanced complex C3. In addition, pre-treating the extracts
with RNase A abolished C3 formation and depending on the probe or
extract used, enhanced complexes C1 and C2 bands in EMSAs.
Complex C3 showed the most specific binding to the T. brucei
G-rich telomere and was the only complex that was not inhibited by any
of the non-telomeric oligonucleotides tested. Cross-competition assays
showed that complex C3 bound slightly better to an RNA oligonucleotide
containing the telomere cognate sequence (tel 1 RNA) than to the
corresponding DNA oligonucleotide (tel 1 DNA). As with yeast Est1p,
C3 also required a free single-strand 3' region for
binding, indicating that it shared properties with Est1p and other
G-rich single-stranded telomere end-binding proteins of yeast (10,
50-53), ciliates (12, 22, 54), and humans (51, 55). The T. brucei telomerase is able to elongate tel 1 RNA,2 which is
consistent with the possibility that, like p80/p95 of Tetrahymena (12) and Est1p of S. cerevisiae (10,
20, 50), the C3 complex may be associated with telomerase activity
and/or telomerase RNA.
An intriguing feature of complex C3 was the possible presence of an
associated RNA component. Complex C3 was highly sensitive to RNase A
and chemical nuclease (hydroxyl radical) activity, and its formation
was almost completely abolished in the presence of these nucleases.
Whether this RNA component corresponds to the TER of T. brucei telomerase is not yet known. Interestingly, complex C3 was
totally inhibited by a 2'-O-methyl RNA oligonucleotide (2'OMe18), cognate to the TTAGGG repeat, and antisense to the hypothetical template region of T. brucei TER (see Ref. 42, and data not shown), although the possibility of association between C3
and 2'OMe18 cannot also be discarded. Primer-extension assays with low
concentrations of 2'OMe18 showed inhibition of T. brucei telomerase activity, possibly through base pairing between 2'OMe18 and
the complementary TER template region.2 The
importance of complex C3 as a component needed for elongation by
telomerase is under investigation.
In size, the C3-associated proteins resemble the 20-kDa Est3p protein
of the S. cerevisiae telomerase complex. Est3p shows a
telomerase-dependent association with telomerase RNA
similar to that of Cdc13p and Est1p and plays an important role in
telomere maintenance (50, 56). In the more extensively characterized telomerase of Tetrahymena, the ability of the
ribonucleoprotein enzyme to bind telomeric oligonucleotides was
distinct from primer elongation efficiency (46). This resemblance is
also consistent with the possibility that, as proposed for Est1p (10,
50) and p80/p95 (12), C3 provides a specific site for primer binding on
the telomerase holoenzyme that is distinct from the telomerase active
site (23).
A preliminary attempt to identify the 18- and 25-kDa protein components
of complex C3 by MALDI-TOF MS analysis, although not totally negative,
revealed some of the inconveniences of dealing with low abundance
proteins, including contamination of the preparation with keratin. The
large scale preparation of C3 should overcome these technical problems
and allow protein sequencing by mass spectrometry for the
identification of these proteins. The lack of homologous proteins based
on the data base searches suggests that the C3-associated proteins are
novel T. brucei proteins.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
·
complex
of Oxytricha nova (22), are indirectly associated with
components of the telomerase holoenzyme and act synergistically with
other molecular components of the telomeric complex (23). Genetics and
biochemical experiments in both yeast and mammals have shown that these
telomere-protein interactions (10-12, 20, 23) are mainly responsible
for (i) regulating telomerase activity (23, 24), (ii) capping the telomere ends to protect them from nuclease digestion or chromosome end-to-end fusion (24-29), (iii) promoting chromosome pairing during mitosis and meiosis (18, 30), (iv) controlling expression of genes
positioned at the telomeres (14, 31), and (v) healing the chromosomes
during events of genome rearrangement (32, 33) and thus are essential
for maintaining genome stability.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]dGTP/µl and 1 unit of Taq
polymerase (Invitrogen). The PCR conditions were as described in Ref.
42. The products were fractionated on 10% sequencing gels and
autoradiographed. Activity in the 500 mM fraction was
tested by pre-treating the extracts with 100 ng of RNase A (Sigma)
for 5 min at 37 °C.
-32P]ATP and
T4 polynucleotide kinase (44). Oligonucleotides OvhF and
tel 3, used to prepare the partial duplex and double-stranded DNAs,
respectively, were radiolabeled with [
-32P]ATP and
T4 polynucleotide kinase prior to mixing with the
complementary OvhR and tel C oligos. Partial duplex 3' G-rich overhang
DNA was obtained by mixing equimolar amounts of radiolabeled OvhF and non-radiolabeled OvhR oligonucleotides followed by heat at 95 °C and
slow cooling at room temperature (10). The partial annealed duplex
containing a 3' overhang of 17 mer was separated from the residual
single-stranded species by purification on a 10% native acrylamide gel
and quantified in a
-counter (10). The double-stranded telomeric DNA
oligonucleotide was also formed after heating the radiolabeled
oligonucleotide tel 3 and non-radiolabeled oligonucleotide tel C at
95 °C, followed by slow cooling at room temperature (40). As tel C
and tel 3 were not completely complementary, the double-stranded species formed with this mixture were end-filled with Klenow DNA polymerase and non-radioactive nucleotide triphosphates (40). The fully
double-stranded DNAs were purified from the residual single-stranded
DNA and quantified as above.
-32P]ATP end-labeled oligonucleotide in a 20-µl
reaction containing 25 mM HEPES, pH 7.5, 5 mM
MgCl2, 0.1 mM EDTA, 100 mM KCl,
10% glycerol, 0.1% Nonidet P-40, 0.5 mM dithiothreitol,
and 100 ng of poly(dI·dC). Samples were incubated on ice for 30 min
before loading onto a 6% native polyacrylamide gel (37.5:1,
acrylamide:bisacrylamide, w/w) in 0.5× TBE (0.05 M
Tris borate and 0.5 mM EDTA, pH 8.3) at 4 °C followed by
electrophoresis at 150 V for 3 h. For autoradiography, wet gels
were exposed to film for 1 h. Quantitative analysis of the
protein·DNA complexes of two independent EMSA was done using the
Scion Image processing and analysis program for the IBM PC (www.scioncorp.com). The autoradiographies were scanned and saved in
TIFF format, and the corresponding images were calibrated before proceeding with the analysis. The results were plotted as shown in
Figs. 1, 2, 3, and 5. The percentage of binding activity of a
shifted complex represents the ratio of the density area (arbitrary scanning units) of each shifted complex and the sum of the density areas of all shifted complexes (including unbound oligo) in each lane,
multiplied by 100.
-32P]ATP end-labeled oligoprobes. The influence of
the order of addition of competitors relative to the probe was compared
by adding the competitors (i) before the probe, followed by 20 min of
incubation on ice, (ii) at the same time as the probe, or (iii) after
the probe, followed by 20 min of incubation on ice. Preliminary
experiments showed no difference in the binding activity between these
three orders of addition. The competition assays were therefore done by
adding the probe and competitor at the same time.
80 °C.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (47K):
[in a new window]
Fig. 1.
Protein·DNA complex formation by T. brucei extracts (S100 and telomerase fraction) incubated
with telomeric DNA oligonucleotides permuted at the 3' end.
A, two-tube TRAP assay (42) to test for the presence of
telomerase activity in S100 (lane 1) and 300-500
mM sodium acetate-DEAE fractions (lanes 2-5).
Telomerase products were fractionated in a 10% sequencing gel, and
enzyme activity was detected by the periodicity of the banding pattern
in the 400 and 500 mM DEAE fractions (lanes
3-5) and by the sensitivity to RNase A (lane 5).
B, EMSA was done with the S100 extract (lane 2)
and the 300-500 mM DEAE fractions (lanes 3-6)
using 5' end-labeled oligonucleotide tel 4. The assay in lane
1 contained no extract, and in lane 6 the DEAE 500 mM fraction was pre-treated with RNase A. The complexes
formed were designated C1, C2, and C3. C, EMSA using S100
and the end-labeled oligonucleotides tel 1 (lanes 1 and
2), tel 2 (lanes 3 and 4), tel 3 (lanes 5 and 6), tel 4 (lanes 7 and
8), and tel 5 (lanes 9-11). The extracts were
pre-treated with RNase A in lanes 2, 4,
6, 8, and 10. Lane 11 shows
an assay done without extract. D, telomerase-positive
fraction (DEAE 500 mM) incubated with the telomeric
oligonucleotides tel 1 (lanes 1-3), tel 2 (lanes
4 and 5), tel 3 (lanes 6 and 7),
tel 4 (lanes 8 and 9), and tel 5 (lanes
10 and 11). The EMSA conditions were the same as in
Fig. 1B. Lanes 3, 5, 7, 9,
and 11 show assays in which extracts were pre-treated with
RNase A. In B, C, and D the amount of
protein-forming complexes is expressed as the percentage of binding
activity as described under "Experimental Procedures."
95% reduction in binding activity of complex
C3 and 10-40% enhancement of complex C2 (bar graph in Fig.
1C). Thus, despite being RNase A-sensitive, complex C3 was
stable and could be detected when the binding reaction was done at
0 °C followed by EMSA at 4 °C (Fig. 1, B-D and data not shown).
50% when tel 3 oligonucleotide was used as probe (Fig.
1D, lane 6 and bar graph). This
probably reflects differences in protein composition in S100 extract
and the telomerase fraction (see Fig. 4).

View larger version (25K):
[in a new window]
Fig. 2.
C3 is specific for the G-rich telomeric
strand of T. brucei. The amount of shifted
complexes in A and B is a rate of two independent
experiments and is expressed as the percentage of binding activity as
described under "Experimental Procedures." A, EMSA using
S100 and tel 4 as a probe, under the same conditions as in Fig. 1, and
with competitors (lanes 4-7). Unlabeled tel 4 (lanes
4 and 5) and T7 (lanes 6 and 7)
were used at concentrations of 0.28 pmol (10 times) and 1.4 pmol (50 times). The reaction mixtures were run on 6% non-denaturing gels in
0.5× TBE at 4 °C. No competitor (NC) was added in
lane 1. Complex C3 was completely eliminated when the
extracts were pre-treated with RNase A (lane 3).
ss, single-strand. B, EMSA using
telomerase-positive fraction (500 mM) and tel 1 as a probe
(lanes 1-6). 50 times molar excess of unlabeled tel 1 was
used as a specific competitor (lane 2). Two unlabeled
T. cruzi subtelomeric oligonucleotides CL9RC (lanes
3 and 4) and CL9F2 (lanes 5 and
6) were used as nonspecific competitors in the same amounts
as in A. No competitor (0×) was added in
lane 1. In A and B, the percentage of
binding activity in the presence of unlabeled competitors showed
p < 0.0001 compared with assays performed in the
absence of competitors (Chi-Square and Fisher's Exact Test).
C, binding of C3 is specific for the G-rich telomeric strand
of T. brucei. EMSAs were done with the telomerase fraction
and 5' end-labeled oligonucleotides tel 1 (lanes 1 and
2), tel C (lanes 3 and 4), Tet
(lane 5 and 6), and T. brucei
double-strand (ds) telomeric DNA (lane 7). RNase
A pre-treatment eliminated complex C3 (lane 2), but other
protein complexes formed with tel C (lane 4) and Tet
(lane 6). The amounts of telomerase-positive fraction,
labeled oligonucleotides, and the reaction conditions are described
under "Experimental Procedures."
Single-stranded oligonucleotides used in EMSA and UV cross-linking

View larger version (19K):
[in a new window]
Fig. 3.
Binding of complex C3 is specific for a free
3' G-rich T. brucei telomeric terminus and involves an
RNA component. A, EMSAs with the telomerase-positive
fraction (500 mM) and tel 1 oligonucleotide (lanes
1 and 2) or a partially duplex G-overhang
(G-overh) DNA (lanes 4 and 5) were
done as described in the legend for Fig. 1. Pre-treating the extract
with RNase A (lane 5) was used to show that the same complex
C3 binds to single-stranded tel 1 and to the G-overhang, although the
complexes formed with the partial duplex showed a different migration
in non-denatured 6% gels. C3* denotes the RNase A-sensitive
complex formed with the telomerase fraction and the G-overhang
DNA. In lanes 3 and 6, no extract was added to
free OvhF (14 fmol) and free G-overhang DNA, respectively.
ss, single-strand. B, the telomerase positive fraction underwent hydroxyl radical
(·OH) treatment prior to binding assays. 0.03% of
hydrogen peroxide (HP) interfered with the binding of the
complexes (lanes 4 and 9). Hydroxyl radical
(·OH) treatment at a lower concentration of peroxide
(0.003%) is shown in lanes 6 (tel 1 DNA) and
11 (tel 1 RNA). Lanes 2 and
8 show the normal binding reaction with tel 1 DNA and tel 1 RNA, respectively. Lane 3 shows extract pre-treated with
RNase A, and lanes 5 and 10 show pre-treatment
with 0.003% hydrogen peroxide followed by binding to tel 1 DNA and tel
1 RNA, respectively. Free tel 1 DNA and free tel 1 RNA are shown in
lanes 1 and 7, respectively. No reagents
(NR) were added to the binding reaction.
and can attack either single- or
double-stranded DNA in a sequential manner. The hydroxyl radical can
also alter protein·DNA and protein·RNA interactions by changing the
nucleic acid conformation or other physical interactions that might
affect the sensitivity of possible substrates to nuclease treatment
(47). Before the binding reactions were done, the hydroxyl radicals
generated in the mixture containing the telomerase fraction were
quenched by adding glycerol. In control experiments, complex C3 was
found to be highly sensitive to up 0.03% hydrogen peroxide (the
binding activity was reduced in 90.3-96.1%), regardless of whether
the binding reaction using the telomerase fraction occurred with tel 1 DNA or tel 1 RNA (Fig. 3B, compare lanes 4 and
9 with lanes 5 and 10). Because
hydroxyl radicals were generated at 0.003% hydrogen peroxide, this was
the concentration chosen for subsequent experiments. Only complex C3
was almost 100% destroyed by hydroxyl radical treatment, as seen with
tel 1 DNA (Fig. 3B, lane 6 and bar
graph) and tel 1 RNA (Fig. 3B, lane 11 and
bar graph) probes. The sensitivity of complex C3 to RNase A
(Fig. 3B, lane 3) and hydroxyl radicals (Fig.
3B, lanes 6 and 11) is consistent with
the presence of an RNA component in the complex.

View larger version (54K):
[in a new window]
Fig. 4.
Approximate mass of single-stranded nucleic
acid-binding proteins of T. brucei based on UV
cross-linking. Proteins in the S100 crude extract and in the 500 mM telomerase-positive fraction were assayed for binding to
the 5' end-labeled tel 1, followed by exposure to UV light (254 nm) at
4 °C. The cross-linked complexes were separated by SDS-PAGE (4-20%
gel) at room temperature. Lanes 1 and 2, S100
extract; lanes 3-8, telomerase fraction; lane 3 shows a binding reaction that was not exposed to UV light. Extracts
were treated with RNase A prior to binding to tel 1 oligonucleotide
(lanes 2 and 6) or DNase I (lane 7). A
50-molar excess (1.4 pmol) of a nonspecific unlabeled competitor was
used in the binding reaction in lane 4. Lane 8 shows a reaction in which bovine serum albumin was not used during the
binding assay. The arrows indicate the nucleoprotein complex
bands (18 and 25 kDa) that possibly correspond to complex C3.

View larger version (16K):
[in a new window]
Fig. 5.
Complex C3 binds an RNA version of the G-rich
telomere sequence. A, EMSAs were done as in Fig. 1
using the telomerase-positive fraction and the cognate tel 1 RNA
(lanes 1-4) or tel 1 DNA oligonucleotides (lanes
5-8). Cross-competition assays were performed using 50 (1.4 pmol)
or 100-fold excess (2.8 pmol) of unlabeled tel 1 DNA oligonucleotide
and labeled tel 1 RNA (lanes 3 and 4) or
unlabeled tel 1 RNA and labeled tel 1 DNA as the probe (lanes
7 and 8). In lanes 1 and 5, no
extract was added to the binding reactions. Arrows are
pointed to the right for complexes C1, C2, and C3. The amount of
shifted complexes was quantified for each experiment and expressed as
the percentage of binding activity as described under "Experimental
Procedures." In the presence of unlabeled competitors
p < 0.01 compared with assays performed in the absence
of competitors (Fisher's Exact Test). ss, single-strand.
NC, no competitors added. B, upper
panel, EMSAs were done after exposing to UV light the binding
reactions using the telomerase fraction and tel 1 RNA; lower
panel, the corresponding UV cross-linked protein·RNA complexes
were separated by SDS-PAGE in a 10% gel. In lanes 3 and
11, RNase A was added before binding; in lanes 4 and 12, the RNase A inhibitor (RNasin) was added at the same
time as RNase A before binding, and in lanes 5 and
13, RNase A was added to the reaction after binding but
before UV cross-linking. Note that complex C3 was partially protected
by RNasin pre-treatment. The extracts were incubated with proteinase K
(PK) before binding to tel 1 DNA in lanes 6 and
14 or to tel 1 RNA oligonucleotides in lanes 7 and 15.

View larger version (59K):
[in a new window]
Fig. 6.
MALDI-TOF MS spectra of complex C3-associated
18- and 25-kDa proteins. A, silver-stained
two-dimensional gels (left) and corresponding
autoradiographs (right) of the 18- and 25-kDa C3-associated
proteins. The numbers assigned correspond to the protein
spots subjected to endoproteinase digestion and MALDI-TOF analysis.
B, mass spectra of the Lys-C-digested spot 2 (i),
spot 4 (ii), spot 5 (iii), and spot 8 (iv) of the 25-kDa protein and spot 2 (v) of the
18-kDa protein. In all profiles, the peaks inside boxes
correspond to the masses (Daltons) used in the data base searches with
Protein Prospector MS-FIT. The peaks corresponding to keratin are
marked with filled circles (on the right).
Peptide standards (Std.) of 1297.43 and 2867.97 Da were used
to calibrate the mass scale.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank colleagues from the Agabian and Blackburn laboratories for helpful discussions during elaboration of the experiments. C. Bloch (Empresa Brasileira de Pesquisa Agropecuária, Brasília, Distrito Federal, Brazil) and M. B. Smolka (Laboratório de Química de Proteínas, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil) kindly helped with the analysis of MALDI-TOF MS spectra, H. P. Pinheiro performed the statistical analysis of the results, and S. Hyslop reviewed the English of the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported in part by National Institutes of Health Grants AI21975 (to N. A. and J. J. B.) and GM26259 (to E. H. B.). M. I. N. C. was supported by postdoctoral fellowships from Fundação de Amparo à Pesquisa do Estado de São Paulo, Brazil and the Pew Latin American Fellows Program in the Biomedical Sciences.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ These authors contributed equally to this work.
To whom correspondence should be addressed: Departamento de
Genética e Evolução, Instituto de Biologia,
Universidade Estadual de Campinas (UNICAMP), CP 6109, Campinas,
São Paulo, 13083-970, Brazil. Tel./Fax 55-19-37886238; E-mail:
micano@unicamp.br.
Published, JBC Papers in Press, October 22, 2001, DOI 10.1074/jbc.M104111200
2 M. I. N. Cano, N. Agabian, and E. H. Blackburn, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: MALDI-TOF MS, matrix-assisted laser desorption-ionization/time of flight mass spectrometry; TRAP, telomere repeat amplification protocol; EMSA, electrophoretic mobility shift assay; TER, telomerase RNA; 2'OMe18, 18mer 2'-O-methyl RNA oligonucleotide.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Greider, C. (1996) Annu. Rev. Biochem. 65, 337-365 |
| 2. | Van Der Ploeg, L. H. T., Lin, A. Y. C., and Borst, P. (1984) Cell 36, 459-468 |
| 3. | Blackburn, E. H., and Challoner, P. B. (1984) Cell 36, 447-457 |
| 4. | Muñoz-Jordan, J., Cross, G., de Lange, T., and Griffith, J. (2001) Nature 20, 579-588 |
| 5. | Cano, M. I. N. (2001) Trends Parasitol. 17, 9425-9429 |
| 6. | Slijepcevic, P. (1998) Exp. Cell Res. 244, 268-274 |
| 7. | Henderson, E., and Blackburn, E. (1989) Mol. Cell. Biol. 9, 345-348 |
| 8. | Wellinger, R., Wolf, A., and Zakian, V. (1993) Cell 72, 51-60 |
| 9. | Mcelligott, R., and Wellinger, R. J. (1997) EMBO J. 16, 3705-3714 |
| 10. | Virta-Pearlman, V., Morris, D., and Lundblad, V. (1996) Genes Dev. 10, 3094-3104 |
| 11. | Nugent, C., Hughes, T., Lue, N., and Lundblad, V. (1996) Science 274, 249-252 |
| 12. | Gandhi, L., and Collins, K. (1998) Genes Dev. 12, 721-733 |
| 13. | Krauskopf, A., and Blackburn, E. H. (1996) Nature 383, 354-357 |
| 14. | Shore, D. (1995) in Telomeres (Blackburn, E. , and Greider, C., eds) , pp. 139-191, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 15. | Krauskopf, A., and Blackburn, E. H. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 12486-12491 |
| 16. | Kirion, G., Liu, K., Liu, C., and Lustig, A. J. (1993) Genes Dev. 7, 1146-1159 |
| 17. | Shore, D. (1997) J. Biol. Chem. 378, 591-597 |
| 18. | Brocolli, D., Smogorzewska, A., Chong, L., and De Lange, T. (1997) Nat. Genet. 17, 231-235 |
| 19. | Li, B., Oestreich, S., and De Lange, T. (2000) Cell 101, 471-483 |
| 20. | Zhou, J., Hidaka, K., and Futcher, B. (2000) Mol. Cell. Biol. 20, 1947-1955 |
| 21. | Lin, J.-J., and Zakian, V. (1994) Nucleic Acids Res. 22, 4906-4913 |
| 22. | Gray, J., Celander, D., Price, C., and Cech, T. (1991) Cell 67, 807-814 |
| 23. | O'Reilly, M., Teichmann, S., and Rhodes, D. (1999) Curr. Opin. Struct. Biol. 9, 56-65 |
| 24. | Lu, Q., Schierer, T., Kang, S., and Henderson, E. (1998) Nucleic Acids Res. 26, 1613-1620 |
| 25. | Froelich-Ammon, S., Dickinson, B., Bevilacqua, J., Schultz, S., and Cech, T. (1998) Genes Dev. 12, 1504-1514 |
| 26. | Smith, C., and Blackburn, E. H. (1999) J. Cell Biol. 145, 203-214 |
| 27. | Van Steensel, B., Smogorzewska, A., and De Lange, T. (1998) Cell 92, 401-413 |
| 28. | Blackburn, E. H. (2000) Nature 408, 53-56 |
| 29. | Chong, L., Van Steensel, B., Broccoli, D., Erdjument-Bromage, H., Hanish, J., Tempst, P., and De Lange, T. (1995) Science 270, 1663-1667 |
| 30. | Cooper, J. P., Watanabe, Y., and Nurse, P. (1998) Nature 392, 828-831 |
| 31. | Bourns, B., Alexander, M., Smith, A., and Zakian, V. (1998) Mol. Cell. Biol. 18, 5600-5608 |
| 32. | Kass-Eiler, A., and Greider, C. (2000) Trends Biochem. Sci. 25, 200-204 |
| 33. | Lanzer, M., Fischer, K., and Le Blancq, S. (1995) Mol. Biochem. Parasitol. 70, 1-8 |
| 34. | Cross, G. (1996) Bioessays 18, 283-291 |
| 35. | Borst, P., Rudenko, G., Taylor, M., Blundell, P., Van Leeuwen, F., Bitter, W., Cross, M., and McCulloch, R. (1996) Arch. Med. Res. 27, 379-388 |
| 36. | Van Der Ploeg, L., Gottesdiener, K., Tse, D., Chung, H., and Weiden, M. (1992) in Mechanisms of Eukaryotic DNA Recombination (Gottesman, M. E. , and Vogel, H. J., eds) , pp. 179-187, Academic Press, New York |
| 37. | Myler, P., Sisk, E., McDonagh, P., Martinez-Calvillo, S., Schnaufer, A., Sunkin, S., Yan, S., Madhubala, R., Ivens, A., and Stuart, K. (2000) Biochem. Soc. Trans. 28, 527-531 |
| 38. | Chiurrillo, M. A., Cano, M. I., Franco, J. S., and Ramirez, J. L. (1999) Mol. Biochem. Parasitol. 100, 173-183 |
| 39. | Eid, J., and Sollner-Webb, B. (1995) Mol. Cell. Biol. 15, 389-397 |
| 40. | Eid, J., and Sollner-Webb, B. (1997) J. Biol. Chem. 272, 14927-14936 |
| 41. | Field, H., and Field, M. (1996) Exp. Parasitol. 83, 155-158 |
| 42. | Cano, M. I., Dungan, J., Agabian, N., and Blackburn, E. H. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 3616-3621 |
| 43. | Bienen, E. J., Hammadi, E., and Hill, G. C. (1981) Exp. Parasitol. 51, 408-417 |
| 44. | Sambrook, J., Fritsch, E., and Maniatis, T. (1989) Molecular Cloning: a Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 45. | Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (eds) (1997) Current Protocols in Molecular Biology , Vol. 2 , John Wiley & Sons, Inc., New York |
| 46. | Harrington, L., Hull, C., Crittenden, J., and Greider, C. (1995) J. Biol. Chem. 270, 8893-8901 |
| 47. | Savery, N., Belyaeva, T., and Busby, S. (1996) in Gene Transcription: DNA-binding Proteins. Essential Techniques Series (Dockerty, K., ed) , pp. 1-5, John Wiley & Sons, Inc., Chichester, United Kingdom |
| 48. | Johnston, S., Lew, J., and Berman, J. (1999) Mol. Cell. Biol. 19, 923-933 |
| 49. | Blasco, M., Gasser, S., and Lingner, J. (1999) Genes Dev. 13, 2353-2359 |
| 50. | Evans, S., and Lundblad, V. (1999) Science 286, 117-120 |
| 51. | Nakayama, J., Saito, H., Nakamura, H., Matsuura, A., and Ishikawa, F. (1997) Cell 88, 875-884 |
| 52. | Le, S., Sternglanz, R., and Greider, C. (2000) Mol. Biol. Cell 11, 999-1010 |
| 53. | Lundblad, V., and Blackburn, E. H. (1993) Cell 73, 347-360 |
| 54. | Gottschling, D., and Zakian, V. (1986) Cell 47, 195-205 |
| 55. | Harrington, L., Mcphail, T., Mar, V., Zhou, W., Oulton, R., Bass, M., Arruda, I., and Robinson, M. (1997) Science 275, 973-977 |
| 56. | Morris, D., and Lundblad, V. (1997) Curr. Biol. 7, 969-979 |
This article has been cited by other articles:
![]() |
|